Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 275

1.

Recognition and repair of compound DNA lesions (base damage and mismatch) by human mismatch repair and excision repair systems.

Mu D, Tursun M, Duckett DR, Drummond JT, Modrich P, Sancar A.

Mol Cell Biol. 1997 Feb;17(2):760-9.

3.

Three-dimensional structural views of damaged-DNA recognition: T4 endonuclease V, E. coli Vsr protein, and human nucleotide excision repair factor XPA.

Morikawa K, Shirakawa M.

Mutat Res. 2000 Aug 30;460(3-4):257-75. Review. Erratum in: Mutat Res 2001 Apr 4;485(3):267-8.

PMID:
10946233
5.

Modulation of MutS ATP-dependent functional activities by DNA containing a cisplatin compound lesion (base damage and mismatch).

Sedletska Y, Fourrier L, Malinge JM.

J Mol Biol. 2007 May 25;369(1):27-40. Epub 2007 Feb 22.

PMID:
17400248
6.

Repair of cisplatin--DNA adducts by the mammalian excision nuclease.

Zamble DB, Mu D, Reardon JT, Sancar A, Lippard SJ.

Biochemistry. 1996 Aug 6;35(31):10004-13.

PMID:
8756462
7.

Specificity of platinum-DNA adduct repair.

Chaney SG, Vaisman A.

J Inorg Biochem. 1999 Oct;77(1-2):71-81.

PMID:
10626357
8.

Human colon cancer cells surviving high doses of cisplatin or oxaliplatin in vitro are not defective in DNA mismatch repair proteins.

Sergent C, Franco N, Chapusot C, Lizard-Nacol S, Isambert N, Correia M, Chauffert B.

Cancer Chemother Pharmacol. 2002 Jun;49(6):445-52. Epub 2002 Apr 20.

PMID:
12107548
9.

Repair of DNA loops involves DNA-mismatch and nucleotide-excision repair proteins.

Kirkpatrick DT, Petes TD.

Nature. 1997 Jun 26;387(6636):929-31.

PMID:
9202128
10.

Human MutSalpha recognizes damaged DNA base pairs containing O6-methylguanine, O4-methylthymine, or the cisplatin-d(GpG) adduct.

Duckett DR, Drummond JT, Murchie AI, Reardon JT, Sancar A, Lilley DM, Modrich P.

Proc Natl Acad Sci U S A. 1996 Jun 25;93(13):6443-7.

13.

ATP-dependent interaction of human mismatch repair proteins and dual role of PCNA in mismatch repair.

Gu L, Hong Y, McCulloch S, Watanabe H, Li GM.

Nucleic Acids Res. 1998 Mar 1;26(5):1173-8.

14.
15.
16.

The role of hMLH1, hMSH3, and hMSH6 defects in cisplatin and oxaliplatin resistance: correlation with replicative bypass of platinum-DNA adducts.

Vaisman A, Varchenko M, Umar A, Kunkel TA, Risinger JI, Barrett JC, Hamilton TC, Chaney SG.

Cancer Res. 1998 Aug 15;58(16):3579-85.

18.

HMG-domain proteins specifically inhibit the repair of the major DNA adduct of the anticancer drug cisplatin by human excision nuclease.

Huang JC, Zamble DB, Reardon JT, Lippard SJ, Sancar A.

Proc Natl Acad Sci U S A. 1994 Oct 25;91(22):10394-8.

19.
20.
Items per page

Supplemental Content

Write to the Help Desk